Related Experiment Video
Updated: Feb 26, 2026

Purification and Aggregation of the Amyloid Precursor Protein Intracellular Domain
Published on: August 28, 2012
Probing APP Cleavage and Amyloid-β Assembly via Synthetic MUC-Type O-Glycosylated APP Glycopeptides
Nancy Vela Navarro1, Gustavo De Nadai Mundim1, Deepika Regmi1
1Department of Chemistry and Biochemistry, Charles E. Schmidt College of Science, Florida Atlantic University, Boca Raton, Florida 33431, United States.
Abstract:
Aberrant proteolytic processing of amyloid precursor protein (APP) can alter amyloid-β (Aβ) peptide trafficking, with recent studies implicating MUC1-type O-glycosylation as a modulatory factor. In this study, we synthesized native and Swedish-mutated (Lys670Asn/Met671Leu) APP glycopeptides spanning the Aβ(1-23) region, including the β- and α-secretase cleavage sites, and introduced O-GalNAc moieties at Thr663, Ser667, and/or Tyr681. Circular dichroism (CD) revealed conformational changes governed by the glycosylation site and glycan density. Increased glycan valency favored the stabilization of β-turn-rich structures typically associated with oligomeric and prefibrillar intermediates. The Swedish mutation enhanced β-secretase (BACE1) cleavage, especially when Ser667 was glycosylated, while additional glycans favored α-secretase (ADAM10) processing. However, this shift was not sufficient to counterbalance the amyloidogenic pathway. Similarly, Ser667 glycosylation promoted fibril formation in coincubation assays with Aβ40, while di- and triglycosylated peptides disrupted fibril architecture and favored oligomer formation, as confirmed by ThT kinetics, AFM/TEM imaging, and dynamic light scattering. These findings highlight the critical role of mutation and site-specific glycosylation in shaping APP proteolytic processing, secondary structure, and aggregation behavior, underscoring their importance for understanding APP function in both healthy and diseased states.
Insights
Aberrant O-glycosylation of amyloid precursor protein (APP) influences its processing and aggregation. Site-specific glycosylation and mutations alter amyloid-beta (Aβ) peptide pathways, impacting Alzheimer's disease pathogenesis.
Area of Science:
- Biochemistry
- Molecular Biology
- Neuroscience
Background:
- Aberrant proteolytic processing of amyloid precursor protein (APP) is linked to amyloid-beta (Aβ) peptide trafficking.
- MUC1-type O-glycosylation is implicated as a factor modulating APP processing.
Purpose of the Study:
- To investigate the impact of site-specific O-glycosylation and the Swedish mutation on APP structure, processing, and aggregation.
- To elucidate how glycosylation at Thr663, Ser667, and/or Tyr681 affects APP's secondary structure and secretase cleavage.
Main Methods:
- Synthesis of native and Swedish-mutated APP glycopeptides with O-GalNAc moieties.
- Circular dichroism (CD) for conformational analysis.
- Analysis of secretase (BACE1 and ADAM10) cleavage.
- In vitro assays (coincubation with Aβ40, ThT kinetics, AFM/TEM imaging, DLS) to study fibril formation and oligomerization.
Main Results:
- Glycosylation site and density influenced APP conformation, with increased valency favoring β-turn-rich structures.
- The Swedish mutation enhanced BACE1 cleavage, particularly with Ser667 glycosylation.
- Additional glycans shifted processing towards ADAM10, but did not fully counteract amyloidogenesis.
- Ser667 glycosylation promoted Aβ40 fibril formation, while di- and triglycosylation disrupted fibrils and favored oligomers.
Conclusions:
- Site-specific glycosylation and mutations critically shape APP proteolytic processing and secondary structure.
- Glycosylation patterns influence APP aggregation behavior, affecting fibril architecture and oligomer formation.
- These findings are crucial for understanding APP function in health and disease, particularly Alzheimer's disease.
More Related Videos
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid Fibrils
Oligosaccharide Assembly
Multiple sugar molecules that may or may...

